DeepMed Research

MEDICAL COLLEGE OF WISCONSIN

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1893-01-01

Employees: 5K

Market Cap: -

Website: http://www.mcw.edu

Clinical Trials

Genetic Basis of Hemangiomas

Terminated

Conditions: Hemangioma, Vascular Anomalies

Interventions: Genetic: Cheek cell samples or blood sample (4mL)
Genetic: Cheek cell sample or blood sample (4mL)

First Posted Date: 2007-04-27

Last Posted Date: 2017-08-29

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 300

Registration Number: NCT00466375

Locations: 🇺🇸
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States

Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes

Completed

Conditions: Hypoplastic Left Heart Syndrome

First Posted Date: 2007-04-20

Last Posted Date: 2019-08-15

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 48

Registration Number: NCT00464100

Locations: 🇺🇸
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States

Erythropoietin and Pediatric Cardiac Surgery

Not Applicable

Terminated

Conditions: Congenital Heart Defect

Interventions: Drug: acyanotic placebo
Drug: acyanotic erythropoietin

First Posted Date: 2007-03-23

Last Posted Date: 2018-11-08

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 9

Registration Number: NCT00451698

Locations: 🇺🇸
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States

Immune Suppression Of Infants Treated With Steroids

Completed

Conditions: Hemangioma

Interventions: Drug: Prednisolone

First Posted Date: 2007-02-12

Last Posted Date: 2013-01-24

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 16

Registration Number: NCT00433940

Locations: 🇺🇸
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

Phase 3

Completed

Conditions: Acute Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Natural Killer Cell Lymphoblastic Leukemia/Lymphoma
Myelodysplastic Syndrome
Acute Myelogenous Leukemia

Interventions: Biological: Single Umbilical Cord Blood Unit Transplant
Biological: Double Umbilical Cord Blood Unit Transplant
Radiation: Total Body Irradiation
Drug: Cyclophosphamide
Drug: Fludarabine
Drug: Cyclosporine A
Drug: Mycophenolate Mofetil

First Posted Date: 2006-12-18

Last Posted Date: 2021-10-28

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 224

Registration Number: NCT00412360

Locations: 🇺🇸
University of Mississippi, Jackson, Mississippi, United States
🇺🇸
Children's Medical Center of Dallas, Dallas, Texas, United States
🇺🇸
New York Medical College, Valhalla, New York, United States

and more 35 locations

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

Phase 3

Completed

Conditions: Leukemia, Lymphocytic, Acute
Myelodysplastic Syndromes
Leukemia, Myelocytic, Acute
Leukemia, Myeloid, Chronic

Interventions: Drug: Tacrolimus
Drug: Methotrexate
Drug: Sirolimus

First Posted Date: 2006-12-04

Last Posted Date: 2023-01-04

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 304

Registration Number: NCT00406393

Locations: 🇺🇸
Stanford Hospital and Clinics, Stanford, California, United States
🇺🇸
Washington University/Barnes Jewish Hospital, Saint Louis, Missouri, United States
🇺🇸
City of Hope National Medical Center, Duarte, California, United States

and more 21 locations

Hemangioma Associated With High Rates of Morbidity

Not Applicable

Completed

Conditions: Hemangioma

Interventions: Device: MRI
Device: MRI of head and neck
Other: Dermatological Examination
Other: Cardiac examination
Device: Abdominal ultrasound

First Posted Date: 2006-11-02

Last Posted Date: 2013-09-20

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 433

Registration Number: NCT00394888

Locations: 🇺🇸
Beth Drolet, MD, Milwaukee, Wisconsin, United States

Robot-Assisted Motivating Rehabilitation

Phase 1

Completed

Conditions: Stroke
Cerebrovascular Accident

First Posted Date: 2006-10-31

Last Posted Date: 2014-02-04

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 24

Registration Number: NCT00393926

Locations: 🇺🇸
Clement J Zablocki VA - Rehabilitation Robotics R&D Lab, Milwaukee, Wisconsin, United States

Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)

Withdrawn

Conditions: Carotid Atherosclerosis

First Posted Date: 2006-10-17

Last Posted Date: 2015-08-24

Lead Sponsor: Medical College of Wisconsin

Registration Number: NCT00388843

Locations: 🇺🇸
Medical College of Wisconsin/Froedtert Memorial and Lutheran Hospital, Milwaukee, Wisconsin, United States

Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)

Phase 1

Completed

Conditions: Anemia, Aplastic

Interventions: Drug: Fludarabine
Drug: Cyclophosphamide 100mg
Drug: Cyclophosphamide 50mg
Drug: Cyclophosphamide 150mg

First Posted Date: 2006-05-16

Last Posted Date: 2021-10-28

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 97

Registration Number: NCT00326417

Locations: 🇺🇸
University of Texas, MD Anderson CRC, Houston, Texas, United States
🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States

and more 19 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy